KRAS and metastatic colorectal cancer: OMITERC (OMIcs application from solid to liquid biopsy for a personalised ThERapy of Cancer) was a data-sharing project aimed to develop a ‘real world’ dataset linking cancer genomic and pharmacogenomics data with clinical outcomes from KRAS mutated metastatic colorectal cancer (mCRC) with the goal to identify a pool of molecular biomarkers useful for the stratification of patients in appropriate risk groups and optimisation of therapeutic regimens.